Bortezomib Completed Phase 2 Trials for Colorectal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00052507Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer